http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11253812-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1010e3862914acdd087e73d76911ec6d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-34
filingDate 1998-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f798ef78c03c447bcb04f18132db1ffb
publicationDate 1999-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H11253812-A
titleOfInvention Method for producing hetero-chiral rare earth catalysts and asymmetric cyclic compounds
abstract PROBLEM TO BE SOLVED: To provide a novel catalyst system capable of carrying out 1,3-cycloaddition of nitrones as a catalytic reaction with high diastereoselectivity and high enantioselectivity, and a novel catalyst system. Provided is a method for producing an asymmetric cyclic compound composed of isoxazolidine used. SOLUTION: An optically active aromatic compound having a phenolic hydroxyl group and an optically active tertiary amine comprising a rare earth (III) compound, an optically active aromatic compound having a phenolic hydroxyl group, and an optically active tertiary amine. Is a hetero-chiral rare earth catalyst in which one is an R-form and the other is an S-form.
priorityDate 1998-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415716027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414848931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID549611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415812034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID305634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421966164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412215776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6350

Total number of triples: 39.